Consider the following statements: I. ELISA test is employed as the first and most basic test for an individual to detect cancer. II. Almost 50 per cent of human beings have Rh+ blood while the remaining have Rh–blood. Which of the statements given above is/are correct?

1. Basics of Human Blood: ABO and Rh Systems (basic)

To understand the complexities of human health and cell biology, we must first understand blood—the fluid connective tissue that serves as our body's primary transport system. Blood consists of a liquid medium called plasma, which carries nutrients and wastes, and specialized cells like Red Blood Corpuscles (RBCs), which are responsible for transporting oxygen Science, Class X (NCERT 2025 ed.), Life Processes, p.91. What defines our 'blood type' are specific proteins called antigens located on the surface of these RBCs. These antigens act like biological ID cards, allowing the immune system to recognize 'self' from 'non-self.'

The ABO system is the most well-known classification, determined by the presence or absence of two antigens: A and B. If you have antigen A, you are type A; if you have both, you are AB; and if you have neither, you are type O. This system is governed by heredity, where certain traits (like blood group A) often show dominance over others (like type O) Science, Class X (NCERT 2025 ed.), Heredity, p.133. Alongside these antigens, the body produces antibodies in the plasma that fight against the antigens you don't have. For example, a person with Type A blood will have Anti-B antibodies.

Equally critical is the Rh (Rhesus) system, which refers to another specific antigen on the RBC surface. You are either Rh-positive (Rh+) if the antigen is present, or Rh-negative (Rh-) if it is absent. A common misconception is that these types are evenly distributed; however, Rh-positive is the overwhelming majority in almost every population, often accounting for 85% to 95% of individuals. This distribution is vital for medical procedures and blood donation camps, which must be strictly regulated to ensure compatibility and safe disposal of biological waste Environment, Shankar IAS Academy (ed 10th), Environmental Pollution, p.91.

Blood Group	Antigen (on RBC)	Antibody (in Plasma)	Can Receive From
A	A	Anti-B	A, O
B	B	Anti-A	B, O
AB	A and B	None	A, B, AB, O (Universal Recipient)
O	None	Anti-A and Anti-B	O (Universal Donor)

Sources: Science, Class X (NCERT 2025 ed.), Life Processes, p.91; Science, Class X (NCERT 2025 ed.), Heredity, p.133; Environment, Shankar IAS Academy (ed 10th), Environmental Pollution, p.91

2. Introduction to the Immune System and Diagnostics (basic)

At its most fundamental level, the immune system is our body’s internal security force, designed to distinguish between 'self' (our own cells) and 'non-self' (invaders like bacteria, viruses, or even rogue cancer cells). When a pathogen—a disease-causing organism—enters the body, the immune system identifies specific proteins on its surface called antigens. Our body then produces antibodies to neutralize these threats. Interestingly, the immune system is a 'learning' system. When it encounters a pathogen for the first time, the response is relatively slow and low-intensity. However, the body creates 'memory' of this encounter. Upon a second exposure to the same pathogen, the immune response is significantly faster and more robust Science, Class VIII . NCERT, Health: The Ultimate Treasure, p.45. This principle of acquired immunity is why we typically only get certain diseases once and why vaccines are so effective. To detect these invisible battles or identify specific threats, we use diagnostic tools like ELISA (Enzyme-Linked Immunosorbent Assay). ELISA is a laboratory technique that relies on the highly specific binding between antigens and antibodies. Think of it as a biological 'lock and key' mechanism. While it is incredibly useful for detecting specific biomarkers—such as certain proteins associated with HIV or specific tumour markers like HER2 in breast cancer—it is important to understand that ELISA is not a 'one-size-fits-all' screening tool. It is used for targeted diagnostics and monitoring rather than as a general, first-stage population screening test for all cancers. Another critical aspect of our biological identity is the Rh factor found on the surface of red blood cells. Just as we identify pathogens by their markers, our own blood cells have markers that determine our blood group. A common misconception is that the population is split evenly between Rh-positive and Rh-negative types. In reality, Rh-positive is the overwhelming majority in almost all global populations, often exceeding 85% to 90%. Understanding these markers is vital not just for blood transfusions, but also for understanding how our immune system might react to foreign tissues or abnormal cell growths, which is the foundational link between immunology and cancer biology.

Sources: Science, Class VIII . NCERT(Revised ed 2025), Health: The Ultimate Treasure, p.45

3. Understanding Cancer: Screening and Detection (intermediate)

Cancer screening is the process of looking for cancer in people who do not yet have any symptoms. The logic is simple: the earlier we find it, the more treatable it is. We move from broad population-level screening (like checking for tobacco habits or UV exposure risks) to specific diagnostic tests. Pioneers like Dr. Kamal Ranadive were instrumental in this field, showing how hormones and environmental factors like pollution and diet increase cancer risk, which helps us decide who needs to be screened more closely Science, Class VIII (NCERT), Health: The Ultimate Treasure, p.37.

One of the most powerful tools in our detection arsenal is Medical Imaging. A primary example is Magnetic Resonance Imaging (MRI). By using strong magnetic fields, we can create detailed internal images of the body to locate tumors that aren't visible to the naked eye. As we've learned, magnetism is not just a physics concept; it has critical applications in life-saving medical diagnosis Science, Class X (NCERT), Magnetic Effects of Electric Current, p.204. Similarly, physical exams can detect abnormalities, such as those caused by tobacco use, which is a major risk factor for oral cancer, particularly in India Science, Class X (NCERT), Life Processes, p.89.

In the laboratory, we use specialized biochemical assays like ELISA (Enzyme-Linked Immunosorbent Assay). While ELISA is a brilliant tool for detecting specific antigens or antibodies (biomarkers), it is important to understand that it is not a "one-size-fits-all" basic screening test for the general population. Instead, it is a targeted diagnostic tool used to confirm or monitor specific conditions. For instance, it can detect certain tumor markers like HER2 in breast cancer. This lab-based detection complements environmental risk assessments, such as monitoring UV-B radiation exposure, which is known to damage DNA and increase the incidence of skin cancers in susceptible populations Environment, Shankar IAS Academy, Ozone Depletion, p.271.

Detection Method	Mechanism	Primary Use
Imaging (MRI/CT)	Magnetic fields/X-rays	Visualizing tumor size and location.
Biochemical (ELISA)	Antigen-antibody reaction	Detecting specific biomarkers in the blood.
Biopsy	Cellular examination	The "Gold Standard" for definitive diagnosis.

Sources: Science, Class VIII (NCERT), Health: The Ultimate Treasure, p.37; Science, Class X (NCERT), Magnetic Effects of Electric Current, p.204; Science, Class X (NCERT), Life Processes, p.89; Environment, Shankar IAS Academy, Ozone Depletion, p.271

4. Biotechnology in Healthcare: DNA and Protein Tests (intermediate)

Biotechnology in healthcare primarily focuses on identifying the molecular "signatures" of a disease. These signatures usually come in two forms: DNA (the blueprint) and Proteins (the functional product). In the context of cell biology and cancer, these tests allow clinicians to determine if a cell is functioning normally or if a pathological change has occurred at the molecular level. Protein-based tests, such as the ELISA (Enzyme-Linked Immunosorbent Assay), utilize the highly specific "lock-and-key" binding between antigens and antibodies. When a disease or cancer causes a cell to produce abnormal proteins (tumor markers), an ELISA can detect and quantify them. However, it is vital to understand that ELISA is a targeted diagnostic tool—used for specific markers like the HER2 protein in breast cancer or viral antigens—rather than a universal, basic screening test for all cancers. Another common protein-based marker is the Rh factor found on red blood cells. In most global populations, Rh-positive individuals constitute the vast majority (often exceeding 85%), which is a critical factor in blood safety and maternal healthcare. DNA-based tests look directly at the genetic code. Techniques like DNA sequencing and DNA barcoding allow scientists to identify specific mutations or species-specific sequences. Large-scale initiatives like BIOSCAN and BARCODE 500K are currently building "libraries of life" to codify these genetic interactions Environment, Shankar IAS Academy, p.248. This infrastructure, supported by specialized diagnostic labs and international informatics platforms, is essential for human capital development and precision medicine Social Science, Class VIII, p.168. Furthermore, during public health emergencies, biotechnology missions like Mission COVID Suraksha accelerate the transition from these diagnostic tests to the development of affordable vaccines and therapeutics Indian Economy, Nitin Singhania, p.618.

Sources: Environment, Shankar IAS Academy, Conservation Efforts, p.248-249; Social Science, Class VIII, Factors of Production, p.168; Indian Economy, Nitin Singhania, Sustainable Development and Climate Change, p.618

5. The ELISA Technique: Mechanism and Applications (exam-level)

The ELISA (Enzyme-Linked Immunosorbent Assay) is a cornerstone of modern medical diagnostics, functioning as a highly sensitive biochemical "search engine" within a blood or tissue sample. At its heart, the technique relies on the specificity of proteins. Just as enzymes are specifically designed to break down only certain substances Science, class X (NCERT 2025 ed.), Our Environment, p.214, antibodies are biological molecules that bind only to their matching antigen (the target substance, like a viral protein or a tumor marker). In an ELISA, we take advantage of this lock-and-key fit to identify if a specific protein is present and in what quantity.

The mechanism involves coating a solid surface (usually a plastic plate) with antibodies. When a patient's sample is added, the target antigen "sticks" to these antibodies. To make this invisible bond visible, a second antibody, which is "linked" to an enzyme, is introduced. Finally, a chemical substrate is added; the enzyme acts upon this substrate to produce a color change. The intensity of the color is directly proportional to the amount of the target substance present. This allows clinicians to not just say "yes" or "no" to a disease, but to accurately quantify the concentration of biomarkers, such as hormones or viral loads.

In the context of Cancer and Cell Biology, ELISA is indispensable for detecting tumor markers—specific proteins produced by cancer cells or by the body in response to cancer. For example, it is used to monitor HER2 levels in breast cancer or PSA (Prostate-Specific Antigen) in prostate health. Beyond cancer, it is the standard screening tool for infectious diseases like AIDS, where it detects HIV antibodies in the blood Environment and Ecology, Majid Hussain, Natural Hazards and Disaster Management, p.80. However, it is important to note that while ELISA is precise, it is typically used for targeted diagnostics and monitoring rather than as a "basic" or universal first-line population screening tool for all cancers.

Component	Role in ELISA
Antigen	The target molecule being measured (e.g., a tumor protein).
Antibody	The "probe" that specifically binds to the target antigen.
Enzyme	The catalyst that triggers a color change for detection.

Sources: Science, class X (NCERT 2025 ed.), Our Environment, p.214; Environment and Ecology, Majid Hussain (Access publishing 3rd ed.), Natural Hazards and Disaster Management, p.80; Science, class X (NCERT 2025 ed.), Heredity, p.131

6. Population Genetics: Blood Group Distribution (exam-level)

To understand how blood groups are distributed across a population, we first look at the ABO system. This is a classic example of codominance and multiple alleles. Unlike many traits governed by just two versions of a gene, the ABO blood group is determined by three alleles: Iᴬ, Iᴮ, and i. While Iᴬ and Iᴮ are codominant (meaning both show up if present together, as in AB blood), they are both dominant over the recessive 'i' allele. In a population, the frequency of these alleles remains relatively stable unless influenced by evolutionary pressures, but the resulting phenotypes (A, B, AB, O) are distributed unevenly across different ethnic and geographic groups. Another critical component of population genetics is the Rhesus (Rh) factor, specifically the Rh(D) antigen. Inheritance here is simpler: it follows a dominant-recessive pattern where being Rh-positive is the dominant trait. In terms of population distribution, there is a common misconception that Rh-positive and Rh-negative types are evenly split. In reality, Rh-positive is the overwhelming majority in almost every global population. For instance, studies in various regions, including India and the Middle East, consistently show Rh-positive frequencies well above 85-90%. This lopsided distribution is a fundamental fact in transfusion medicine and population studies. While we study these genetic markers to understand inheritance, we use laboratory techniques like ELISA (Enzyme-Linked Immunosorbent Assay) to detect them or other proteins in the blood. In the context of broader biology and oncology, ELISA is a highly sensitive tool used to measure specific biomarkers (such as the HER2 protein in certain cancers) or antibodies. However, it is important to distinguish between a diagnostic tool and a population screening tool. ELISA is typically used for targeted diagnostics and monitoring rather than serving as a universal, 'first-step' screening test for the general population. Just as population density in India varies by geography and climate India People and Economy, Population: Distribution, Density, Growth and Composition, p.14, the presence of specific biomarkers in a population is studied to understand disease prevalence and genetic health.

Sources: India People and Economy, Population: Distribution, Density, Growth and Composition, p.14

7. Solving the Original PYQ (exam-level)

This question masterfully integrates your knowledge of biotechnological diagnostics and human genetics. You have previously learned that ELISA (Enzyme-Linked Immunosorbent Assay) is a versatile tool used to detect antigens and antibodies, but its application is context-specific. Similarly, your study of blood groups highlighted that the Rh factor is a dominant genetic trait. This PYQ tests whether you can distinguish between a tool's theoretical capability and its standard clinical protocol, while also checking your grasp of population genetics versus simple probability.

To arrive at the correct answer, (D) Neither I nor II, we must evaluate the specific wording used by the examiner. Statement I is an over-generalization trap; while ELISA is used to monitor specific biomarkers like HER2 in certain cancers, it is not the "first and most basic" universal screening test for cancer—a role typically reserved for imaging, biopsies, or specific screenings like Pap smears. It is most famously the primary screening for HIV/AIDS. Statement II is a statistical trap; because Rh-positive is a genetically dominant trait, it is far more prevalent than Rh-negative. Global data, such as that found in Nature and WHO Regional Surveys, indicates that roughly 85-95% of most populations are Rh-positive, rendering the "50 per cent" claim factually incorrect.

Options (A), (B), and (C) are incorrect because they rely on the validity of these flawed premises. UPSC often uses absolute descriptors like "most basic" or "universal" to make a statement factually vulnerable. By recognizing that biological distributions are rarely a 50/50 split and that cancer diagnostics require a more complex, multi-tiered approach than a single ELISA test, you can effectively eliminate the distractors and identify that neither statement holds up under rigorous scientific scrutiny.